Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T gondii infection
- PMID: 32249951
- DOI: 10.1111/pim.12716
Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T gondii infection
Abstract
Aims: Neuroinflammation can manifest upon infection with the neurotropic parasite Toxoplasma gondii (ME49), which can lead to brain injury and cognitive dysfunction. Rhoptry organelle proteins (ROPs) secreted by T gondii play critical roles in host invasion.
Methods and results: In this study, influenza virus-like particles (VLPs) expressing T gondii ROP4 or ROP13 were generated to assess vaccination-induced changes in intracranial pro-inflammatory cytokines and antibody responses upon T gondii challenge infection. Compared to ROP13 VLPs, ROP4VLPs vaccination significantly limited the production of pro-inflammatory cytokines IFN-γ and IL-6 in the brains of mice. Reduced pro-inflammatory cytokine responses by ROP4 VLPs and ROP13 VLPs correlated with significantly increased T gondii-specific IgG and IgA antibody responses in the brain, as well as IgG, IgG1 and IgM antibody responses in the sera.
Conclusion: We concluded that influenza T gondii VLP vaccination induces antibody responses in sera and brain, which may contribute to the significant reduction of neuroinflammation during T gondii infection.
Keywords: ROP13; ROP4; Toxoplasma gondii ME49; pro-inflammatory cytokine; vaccine; virus-like particle.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection.Korean J Parasitol. 2018 Oct;56(5):429-435. doi: 10.3347/kjp.2018.56.5.429. Epub 2018 Oct 31. Korean J Parasitol. 2018. PMID: 30419728 Free PMC article.
-
Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection.Vaccine. 2018 Sep 11;36(38):5692-5700. doi: 10.1016/j.vaccine.2018.08.016. Epub 2018 Aug 11. Vaccine. 2018. PMID: 30107996
-
Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection.Pharmaceutics. 2019 Jul 16;11(7):342. doi: 10.3390/pharmaceutics11070342. Pharmaceutics. 2019. PMID: 31315212 Free PMC article.
-
Noradrenergic Signaling and Neuroinflammation Crosstalk Regulate Toxoplasma gondii-Induced Behavioral Changes.Trends Immunol. 2020 Dec;41(12):1072-1082. doi: 10.1016/j.it.2020.10.001. Epub 2020 Nov 16. Trends Immunol. 2020. PMID: 33214056 Review.
-
Using Protozoan Surface Proteins for Effective Oral Vaccination.Trends Parasitol. 2020 Jan;36(1):7-10. doi: 10.1016/j.pt.2019.07.004. Epub 2019 Jul 27. Trends Parasitol. 2020. PMID: 31362858 Review.
Cited by
-
Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice.Front Cell Infect Microbiol. 2021 Sep 29;11:735191. doi: 10.3389/fcimb.2021.735191. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34660343 Free PMC article.
-
β-Glucan alleviates goal-directed behavioral deficits in mice infected with Toxoplasma gondii.Parasit Vectors. 2023 Feb 13;16(1):65. doi: 10.1186/s13071-023-05686-4. Parasit Vectors. 2023. PMID: 36782332 Free PMC article.
-
Virus-Like Particle Vaccines Against Respiratory Viruses and Protozoan Parasites.Curr Top Microbiol Immunol. 2021;433:77-106. doi: 10.1007/82_2021_232. Curr Top Microbiol Immunol. 2021. PMID: 33650036 Review.
-
Evaluation of CpG-ODN-Adjuvanted Toxoplasma Gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations.Pharmaceutics. 2020 Oct 19;12(10):989. doi: 10.3390/pharmaceutics12100989. Pharmaceutics. 2020. PMID: 33086673 Free PMC article.
-
Global MicroRNAs Expression Profile Analysis Reveals Possible Regulatory Mechanisms of Brain Injury Induced by Toxoplasma gondii Infection.Front Neurosci. 2022 Mar 10;16:827570. doi: 10.3389/fnins.2022.827570. eCollection 2022. Front Neurosci. 2022. PMID: 35360170 Free PMC article.
References
REFERENCES
-
- Lopes FMR, Gonçalves DD, Mitsuka-Breganó R, Freire RL, Navarro IT Toxoplasma gondii infection in pregnancy. Brazilian J Infect Dis. 2007;11:496-506.
-
- Konradt C, Ueno N, Christian DA, et al. Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system. Nat Microbiol. 2016;1:16001.
-
- Parlog A, Harsan LA, Zagrebelsky M, et al. Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis Model Mech. 2014;7:459-469.
-
- Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 2009;39:895-901.
-
- Eyles DE, Coleman N. Antibiotics in the treatment of toxoplasmosis. Am. J. Trop. Med. Hyg. 1953;2:64-69.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous